# Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances

> **NCT01839578** · NA · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 30 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Anticoagulation to prevent clotting of the extracorporeal circuit. (regional citrate anticoagulation)
- **DRUG:** Anticoagulation to prevent clotting of the extracorporeal circuit (Unfractionated heparin)

## Key facts

- **NCT ID:** NCT01839578
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2014-11
- **Final completion:** 2015-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01839578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01839578, "Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01839578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*